Dr. John O'Connell
Claim this profilePrisma Health - Upstate
Studies Non-Small Cell Lung Cancer
Studies Brain Cancer
1 reported clinical trial
2 drugs studied
Affiliated Hospitals
More about John O'Connell
Clinical Trial Related8 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments John O'Connell has experience with
- NovoTTF-100M Device
- NovoTTF-200M Device
Breakdown of trials John O'Connell has run
Non-Small Cell Lung Cancer
Brain Cancer
Lung Cancer
Brain metastases
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does John O'Connell specialize in?
John O'Connell focuses on Non-Small Cell Lung Cancer and Brain Cancer. In particular, much of their work with Non-Small Cell Lung Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is John O'Connell currently recruiting for clinical trials?
No, John O'Connell is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that John O'Connell has studied deeply?
Yes, John O'Connell has studied treatments such as NovoTTF-100M device, NovoTTF-200M device.
What is the best way to schedule an appointment with John O'Connell?
Apply for one of the trials that John O'Connell is conducting.
What is the office address of John O'Connell?
The office of John O'Connell is located at: Prisma Health - Upstate, Greenville, South Carolina 29605 United States. This is the address for their practice at the Prisma Health - Upstate.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.